Blood collection techniques, heparin and quinidine protein binding.
Kessler KM, Leech RC, Spann JF
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of collection and storage container, heparin sulfate administration and collection method on the percentage of unbound quinidine in blood from healthy subjects and patients with congestive heart failure, chronic renal failure, or a cardiac catheter. Blood was stored for 24 h at 4 degrees C prior to analysis.
Summary of Findings
Blood collected into or stored in red or green stoppered Vacutainer tubes for 24 h at 4 degrees C had higher concentrations of quinidine then blood collected and stored in all glass systems. There was a similar fraction of unbound quinidine in healthy control subjects and patients with congestive heart failure or chronic renal failure, but the fraction of unbound quinidine increased (p<0.0001) during cardiac catheterization. The elevation of quinidine during cardiac catheterization occurred simultaneously with heparin administration and was found both when the specimen was collected by venipuncture or through the catheter.
Biospecimens
FluidBloodPreservation Types
None (Fresh)Diagnoses
Cardiovascular DiseaseNormalOther diagnosesPlatforms
Small moleculeFluorometryPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition Chronic renal failureCongestive heart failureNormal volunteerBiospecimen Acquisition Anatomical location of blood draw HeartPeripheral veinBiospecimen Acquisition Method of fluid acquisition Cardiac catheterVenipunctureBiospecimen Acquisition Time of biospecimen collection After cardiac catheterization/heparin injectionAt time of heparin injectionPrior to heparinBiospecimen Acquisition Type of collection container/solution Glass syringeGreen-stoppered VacutainerRed-stoppered VacutainerStorage Type of storage container Glass-stoppered tubeGreen-stoppered tubeRed-stoppered tube